Pediatric Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Food and Drug Administration (FDA) is correcting a notice entitled "Pediatric Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments." The document announced a meeting of the Pediatric Advisory Committee. The document was published with the incorrect docket number and end time of the meeting. This document corrects those errors.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 170 (Tuesday, September 7, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 170 (Tuesday, September 7, 2021)]
[Notices]
[Page 50134]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-19216]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2021-N-0944]
Pediatric Advisory Committee; Notice of Meeting; Establishment of
a Public Docket; Request for Comments; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a notice
entitled ``Pediatric Advisory Committee; Notice of Meeting;
Establishment of a Public Docket; Request for Comments.'' The document
announced a meeting of the Pediatric Advisory Committee. The document
was published with the incorrect docket number and end time of the
meeting. This document corrects those errors.
FOR FURTHER INFORMATION CONTACT: Marieann Brill, Office of the
Commissioner, Food and Drug Administration, 10903 New Hampshire Ave.,
Bldg. 32, Rm. 5154, Silver Spring, MD 20993, 240-402-3838, or FDA
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in
the Washington, DC area). Please call the Information Line for up-to-
date information on this meeting.
SUPPLEMENTARY INFORMATION: In the Federal Register of Tuesday, August
10, 2021, in FR Doc. 2021-16984 (86 FR 43666), the following
corrections are made.
1. On page 43666, in the first column, in the header of the
document, and in the third column under ``Instructions,'' ``Docket No.
FDA-2020-N-1648N'' is changed to ``Docket No. FDA-2021-N-0944''.
2. On page 43666, in the first column, the DATES portion of the
document is changed to: ``The meeting will be held on September 17,
2021, from 10 a.m. to 3 p.m. Eastern Time.''
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.
Dated: August 31, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-19216 Filed 9-3-21; 8:45 am]
BILLING CODE 4164-01-P
</pre></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.